Dr. Howard Smith Oncall

  Vidcast:  https://youtu.be/JhQ4qo4s5cE   Moderna Therapeutics, Cambridge, MA has shipped first batches of its CoVid19 vaccine to be used for clinical testing in April.  This vaccine was developed using a cutting edge genetic method employing messengerRNA that codes for Coronavirus proteins.  The mRNA triggers lymph node production of immune cells that attack the virus.  It will require a year of trials and testing before we have a usable vaccine. Other vaccines are in development: Novavax using spike protein as antigen; Sanofi Pasteur with work with US government; Takes and Evvivax in Italy.   https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30079-5/fulltext   #covid19 #coronavirus #epidemic #pandemic #vaccine